Executive Committee

The Executive Committee comprises the following permanent members.

Paul Hudson

Paul Hudson

Chief Executive Officer

Term expires 2026

Houman Ashrafian

Executive Vice President, Head of Research and Development

Natalie Bickford - Executive Vice President, Chief People Officer

Natalie Bickford

Executive Vice President, Chief People Officer

Olivier Charmeil - Executive Vice President, General Medicines

Olivier Charmeil

Executive Vice President, General Medicines

Audrey Duval, Executive Vice President, Corporate Affairs

Audrey Duval

Executive Vice President, Corporate Affairs

Brian Foard

Brian Foard

Executive Vice President, Head of Specialty Care

Emmanuel Frenehard

Emmanuel Frenehard

Executive Vice President, Chief Digital Officer

Brendan O’Callaghan - Executive Vice President, Manufacturing and Supply

Brendan O’Callaghan

Executive Vice President, Manufacturing and Supply

Roy Papatheodorou - Executive Vice President, General Counsel

Roy Papatheodorou

Executive Vice President, General Counsel

Madeleine Roach, Executive Vice President, Business Operations

Madeleine Roach

Executive Vice President, Business Operations

François-Xavier Roger, Executive Vice President, Chief Financial Officer

François-Xavier Roger

Executive Vice President, Chief Financial Officer

Thomas Triomphe - Executive Vice President, Vaccines

Thomas Triomphe

Executive Vice President, Vaccines

Julie Van Ongevalle - President and Chief Executive Officer, Opella

Julie Van Ongevalle

President and Chief Executive Officer, Opella